consist of: escalating D1 and D2 dopamine receptor density throughout the striatum; inducing norepinephrine launch (to promote ?2 receptors); increasing serotonin release in the hippocampus; and suppressing adrenomedullary action. As a comparatively new phenomenon, novel psychoactive substances (NPS) belonging to your BZD class have emerged in the